Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Field&flower are a trusted retailer of ethical meat, fish and cheese. They provide grass fed, free range meat boxes to over 4500 active subscription customers. They were profitable in 16/17 with a revenue of £2.7m and are now looking to expand and become a major online food retailer.
days to go:
Expired
investment:
£877,030
DABBOUS is a highly successful, Michelin starred, modern fine-dining restaurant and bar in central London. Opened in January 2012 by Ollie Dabbous and Oskar Kinberg, DABBOUS offers innovative style and creative interpretation of modern European cuisine in an industrial setting.
days to go:
Expired
investment:
£3,124,165
HaMuch is an online platform that lets homeowners compare hourly rates of local tradespeople and check their availability. The company has provided digital marketing services to businesses such as Travis Perkins, HomeServe, and Rated People. About 200,000 tradespeople have uploaded their profiles on the platform with 12,000+ having uploaded their respective prices. The company has been featured in The Sunday Telegraph, Express, Sun, and Microsoft News.
days to go:
Expired
investment:
£132,850
A themed cocktail bar owner, craft beer brewer and gin brand creator that serves thousands of customers on a weekly basis. Liquid Art Group currently have 3 locations within affluent areas of Manchester and are now raising funds to open 12 more sites across the UK over the next 3 years. The company has become highly profitable and are ready to duplicate their proven business model after successfully running in a niche area of their market.
More sites will result in reduced costs due to purchasing bulk goods from existing suppliers in greater quantities. This means that profit margins will increase, whilst more locations will provide additional streams of revenue. Liquid Art Group is also planning to develop and distribute their range of gin by creating new flavours and offerings.
days to go:
Expired
investment:
£129,080
Milbotix, a healthtech start-up, supported by the Alzheimer's Society and the UK Dementia Research Institute, is driven by its innovative product SmartSocks™. This wearable technology aims to assist individuals with dementia facing communication challenges and their caregivers. Globally, the number of people with dementia is increasing significantly, reaching 78 million by 2030 and 139 million by 2050. Half of those diagnosed with dementia encounter challenging behavioral symptoms due to distress. Early distress management not only enhances well-being but also helps prevent escalating behavioral issues. SmartSocks™ utilize sensors and artificial intelligence to notify dementia caregivers about early signs of pain and anxiety in their patients.
days to go:
Expired
investment:
£220,780
Hitmarker is a proprietary job platform that covers the entire video game sector. It aims to be the leading job provider in the $159 billion video game industry. It has a database of 67,000 candidates and has posted 46,000 jobs from 4,500 companies in 77 countries. The company asserts that one million people have used Hitmarker 2.5 million times to post or look for jobs. Hitmarker has been covered by publications like Forbes, CNBC, and The FT. It has also onboarded 20 partners, including The University of California, RGF Executive Search, and the British Esports Association. The company will use the investment to build a global network of localised platforms in crucial territories and expand its addressable market.
days to go:
Expired
investment:
£521,283
